Viewing Study NCT01116193


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:27 PM
Study NCT ID: NCT01116193
Status: COMPLETED
Last Update Posted: 2017-09-14
First Post: 2010-04-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia
Sponsor: Institut de Cancérologie de la Loire
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module